Stock events for Corteva, Inc. (CTVA)
Corteva reported strong first-quarter financial results with operating EPS increasing by 27% and GAAP EPS from continuing operations rising by 83%. Argus Research upgraded Corteva's outlook from Hold to Buy, and Goldman Sachs initiated coverage with a Buy recommendation. Corteva announced a quarterly common stock dividend of $0.17 per share. Corteva announced a multi-year research collaboration with Micropep Technologies to develop peptide-based biocontrol solutions for agriculture. Corteva's stock price has increased by 18.45% over the past six months. An ongoing lawsuit by the Federal Trade Commission against Syngenta and Corteva, challenging certain discount programs, with a motion to dismiss denied in January 2024, could be a continuing factor for investors. Additionally, a patent-related case with Bayer was paused in May 2025. Insider selling has also been noted recently.
Demand Seasonality affecting Corteva, Inc.’s stock price
Corteva's sales are significantly influenced by the seasonality of the agricultural industry. Approximately 65% of its sales typically occur in the first half of the calendar year, aligning with the planting and growing seasons in the northern hemisphere. The remaining 35% of sales are generated in the second half of the year, primarily driven by seed sales in the southern hemisphere. Unfavorable weather conditions can also lead to fluctuations in quarterly results and overall sales.
Overview of Corteva, Inc.’s business
Corteva, Inc. is a global pure-play agriculture company providing seed and crop protection solutions. It operates in the Basic Materials sector, specifically in the Agricultural Inputs industry. The company's core business areas include seed technology, which develops advanced germplasm and traits for crops; crop protection, which offers solutions such as herbicides, insecticides, and fungicides; and digital agriculture, which provides tools and services to optimize crop management.
CTVA’s Geographic footprint
Corteva has a significant global presence, operating in over 110 countries. Approximately half of its revenue is generated from North America. The company also has a strong market share and is expanding rapidly in Latin America, particularly in Brazil, for soy and corn. Other key regions include Europe, the Middle East, and Africa (EMEA), and the Asia-Pacific region.
CTVA Corporate Image Assessment
Corteva's brand reputation has been influenced by its operational activities and commitment to sustainability. Sustainalytics assigned Corteva a "Significant" controversy level related to "Incidents: Operations." Corteva's 2024 Impact Report highlights advancements in sustainable agriculture through technology. In 2024, Corteva engaged in constructive dialogue with stockholders on its business and innovation strategy, corporate governance, sustainability priorities, and human capital management. Corteva Agriscience has not seen a significant change in news mentions over the last month and underperforms its industry peers in this metric.
Ownership
Corteva's ownership is predominantly institutional, with 84.64% held by institutional shareholders. Retail investors account for 15.02% of ownership, while Corteva insiders hold a smaller portion at 0.33%. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., State Street Corp, Aristotle Capital Management, LLC, Capital International Investors, Capital World Investors, Geode Capital Management, Llc, and Franklin Resources Inc. Company insiders own less than 1% of the stock and have recently been selling shares.
Ask Our Expert AI Analyst
Price Chart
$75.03
Top Shareholders
Sentiment for CTVA
Loading...
Loading...
Loading...